US EditionLercanidipine: Patients urged to check blood pressure medication after labelling error
- Patients taking Lercanidipine should verify their medication due to a labeling error reported by the Medicines and Healthcare Products Regulatory Agency .
- One batch of Lercanidipine is incorrectly labeled as 10mg tablets but actually contains 20mg, according to the MHRA alert.
- Over 7,700 packs of the affected medicine have been distributed, prompting a recall, the MHRA stated.
- Healthcare professionals are advised to stop supplying this batch and return it to the supplier, as emphasized by Dr. Alison Cave, Chief Safety Officer at MHRA.
Insights by Ground AI
Does this summary seem wrong?
13 Articles
13 Articles
All
Left
5
Center
2
Right
Patients urged to check packs of blood pressure medicine lercanidipine after labelling error
Patients who take the common blood pressure medicine Lercanidipine HCI 20 mg tablets (lercanidipine hydrochloride) from the manufacturer Recordati Pharmaceuticals Limited, should, as a precautionary measure, urgently check if they have the batch number MD4L07 with an expiry date of 01/2028 on any packs they have at home.
·United States
Read Full Article
Coverage Details
Total News Sources13
Leaning Left5Leaning Right0Center2Last UpdatedBias Distribution71% Left
Bias Distribution
- 71% of the sources lean Left
71% Left
L 71%
C 29%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
